NDC properties for NDC 9 0025-0329
NDC item 00025032901
| NDC 9 | 0025-0329 |
|---|---|
| NDC 10 | 0025-0329-01 |
| NDC Item | 00025032901 |
| packaging | 0.4 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | active |
NDC item 00025033302
| NDC 9 | 0025-0333 |
|---|---|
| NDC 10 | 0025-0333-02 |
| NDC Item | 00025033302 |
| packaging | 2 KIT in 1 CARTON (0025-0333-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (0025-0329-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
NDC item 00069032901
| NDC 9 | 0069-0329 |
|---|---|
| NDC 10 | 0069-0329-01 |
| NDC Item | 00069032901 |
| packaging | 0.4 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | active |
NDC item 00069033302
| NDC 9 | 0069-0333 |
|---|---|
| NDC 10 | 0069-0333-02 |
| NDC Item | 00069033302 |
| packaging | 2 KIT in 1 CARTON (0069-0333-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (0069-0329-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |